
Cloud-hosted, no-code-configurable LIMS combining sample lineage, freezer inventory, instrument-data ingest, configurable workflow jobs, and an integrated ELN, with published list pricing and bundled implementation.
LabKey LIMS launched in 2025 from LabKey, a bootstrapped Seattle vendor building scientific data management software since 2003 as a Fred Hutchinson Cancer Research Center spinout. It is the LIMS Starter and LIMS Enterprise editions of a five-edition LIMS Suite — Sample Manager Starter, Sample Manager Professional, LIMS Starter, LIMS Enterprise, Biologics LIMS — all running on the open-source LabKey Server platform, with one help tree and one release train. Each edition is a strict superset of the one before it: LIMS Starter adds reporting, analytics, and data transformation over Sample Manager Professional; LIMS Enterprise adds Enterprise Data Governance and Integrations & Extensibility; Biologics LIMS adds entity registration, plate management, and media registration.
The product is sample-centric: lab administrators define sample types, fields, and status workflows without code, enforced at registration, and sample lineage covers derive, pool, and aliquot with expiration tracking and real-time chain of custody. Freezer inventory, instrument-data ingest, and an ELN with electronic signatures and structured sign-off sit in the same system.
LabKey does not market LabKey LIMS for commercial GMP batch release. It states that LabKey LIMS supports 21 CFR Part 11 and runs a validation programme through CompliancePath, refreshed per Extended Support Release; it publishes no clause-level Part 11 mapping, GAMP 5 category, or pre-validated SKU, and validation is an unpriced add-on. List pricing is published: $34,080/year for LIMS Starter and $53,520/year for LIMS Enterprise. Named customers include Fred Hutch, NIH, Takeda, and Bristol Myers Squibb, none attached to a named product.
Vendor-hosted cloud only; secure cloud hosting is included in every plan. On-premise is offered for Biologics LIMS alone, as a separately priced add-on. Browser-based access. API access is included and the public API documentation at labkey.org is ungated. Authentication supports LDAP, CAS, SAML, and Duo two-factor. Hosting runs dedicated virtual servers with VLAN segmentation, managed firewalls, encryption, OS- and web-application-level vulnerability scanning, and intrusion detection and prevention.
Instrument data arrives through file watchers and transformation scripts that normalize any output format; Tableau, Power BI, and RStudio connectors cover analysis. File Watchers, ETLs, external database connections, ODBC/JDBC, SSO, and custom SQL are LIMS Enterprise capabilities; LIMS Starter does not include them (vendor-confirmed 2026-08-13). An MCP server shipped in release 26.3 (March 2026) and was extended in 26.7 for desktop AI agents.
Releases are monthly, numbered year.month, unbroken across 25.1 to 25.12 and 26.1 to 26.7 (July 2026). Validated installations track designated Extended Support Releases instead — 25.7.8, 26.3.8, and 26.3.14 in the current notes — each folding in the intervening monthly work. LabKey states that on-premise and cloud customers alike can join the ESR cycle at any point (by email, 2026-08-13). LabKey Server, the underlying platform, is open source with a free Community Edition.
Subscription only; no perpetual license is marketed. List pricing is published: LIMS Starter $34,080/year and LIMS Enterprise $53,520/year, each including 10 users, or the equivalent $284 per user per month at a 10-user minimum, billed annually. Adjacent editions list at Sample Manager Starter $6,540/year and Professional $13,140/year, 5 users included. Volume and multi-year discounts are offered.
Every plan includes implementation and onboarding, training and support, audit-ready records, cloud hosting, and migration assistance, with no other setup costs or fees. Two add-ons sit outside the list price, neither restricted to a tier: HIPAA compliance support and software validation services. The $19,440/year step from Starter to Enterprise buys the SDMS layer. Undisclosed: incremental per-seat cost above the bundled 10 users, storage limits, and pricing for either add-on.
Pricing Model
Subscription
Typical Deal Size
$34,080-53,520/year
LabKey markets go-live "in weeks, not months"; its own generic guidance on the same page allows "a few weeks to several months" depending on customization and lab size. Implementation, onboarding, training, support, and migration are bundled into every plan; there is no separate services engagement. Extracting and cleaning incumbent data remains customer-side work, and is not a vendor line item.
Administrators adjust sample types, fields, and workflow definitions without a support ticket or a developer. Public, ungated documentation at labkey.org/limshelp covers the sample, storage, assay, workflow, ELN, and administration modules.
Validation is the one unpriced implementation cost for a regulated lab: PQ is either purchased as Phase 2 of the Validation Pack or prepared and executed by the customer (LabKey, by email 2026-08-13), and staffing the staging and production upgrade windows on LabKey's regional rollout schedule is customer-side either way.
PharmaSpotter assessment from published vendor and third-party sources. No user reviews are on file for this product.
Third-party review volume is too thin to summarize: 4.6/5 across 10 G2 reviews, all of LabKey Server rather than the 2025 LIMS product. Published list pricing. Implementation, training, and support bundled into the subscription. Ungated public documentation covering every module. An open-source Community Edition of the platform. No-code configuration: lab administrators define sample types and workflows without a support ticket. Twenty years of operation without outside capital. Releases monthly and unbroken across 25.1 to 26.7. The validation programme is published in advance: a named partner, a defined Validation Pack, an Extended Support Release line, and a dated upgrade calendar.
LabKey states Part 11 support but publishes no clause-level Part 11, EU Annex 11, GAMP 5, or ALCOA+ mapping. No pre-validated SKU; the validation add-on is scoped but unpriced, and PQ sits outside the pack, purchased as Phase 2 or performed by the customer (2026-08-13). HIPAA support is a paid add-on. No completed SOC 2 Type II report and no ISO 27001; the examination is in flight. The LIMS editions are cloud only; on-premise exists only on Biologics LIMS at $59,400/year plus an installation add-on. File Watchers, ETLs, external database connections, ODBC/JDBC, and SSO are Enterprise-tier, vendor-confirmed (2026-08-13), though the product page markets file watchers untiered. Each Extended Support Release brings a validation cycle; validated customers may not defer or decline an upgrade and keep their validated status, regression testing sits in LabKey's SDLC rather than in per-release customer evidence (LabKey, 2026-08-13), and ESR support duration is undisclosed. Part 11 and validation answers sit in an FAQ PDF and the labkey.org help tree rather than on the marketing site. Roughly 42 employees across five product lines and seven verticals. Takeda and Bristol Myers Squibb are company-level logos predating the 2025 LIMS product; no case study names LabKey LIMS, and LabKey was unable to name a LabKey LIMS reference when asked (2026-08-13).
Share your experience with LabKey LIMS anonymously. Your insights help pharmaceutical professionals make better software decisions.
Contribute Anonymous FeedbackPublicly disclosed pharmaceutical and biotech organizations
Jump to section